ALLERGY is a leading international journal published by WILEY, dedicated to advancing the understanding of allergic diseases and immunology. With an ISSN of 0105-4538 and an E-ISSN of 1398-9995, this esteemed journal has been at the forefront of the field since its inception in 1948 and continues to publish high-quality research up until 2024. Positioned in the Q1 category for both Immunology and Allergy, ALLERGY ranks impressively within the top percentiles of its categories, underscoring its significant impact, as reflected in its Scopus rankings (#11 out of 233 in Immunology and Allergy, and #14 out of 236 in Immunology and Microbiology). Researchers and practitioners accessing this journal can expect a rigorous selection of peer-reviewed articles that address current challenges, innovative therapies, and advancements in the immunological sciences. Although it is not an open-access journal, ALLERGY remains vital for academics, healthcare professionals, and students alike, fostering a deeper understanding of the mechanisms and treatments associated with allergies.

CLINICAL AND EXPERIMENTAL ALLERGY is a premier peer-reviewed journal dedicated to advancing the scientific understanding of allergy and immunology. Published by Wiley in the United Kingdom, this esteemed journal maintains a significant impact factor, reflecting its high standards and influential research contributions. With an impressive history since its inception in 1971, the journal is poised to continue leading the discourse in the field until at least 2024. It is ranked in the Q2 quartile for both Immunology and Allergy categories, further highlighting its reputable standing within the academic community. The journal's Scopus rankings showcase its academic relevance, securing the 49th and 51st positions in the Medicine and Immunology categories, respectively. Researchers, professionals, and students will find vital insights and contemporary research trends within its pages, making it an essential resource for those invested in understanding and addressing allergic diseases and disorders.

Asia Pacific Allergy, published by Lippincott Williams & Wilkins, is a prominent academic journal dedicated to advancing research and clinical practice in the fields of dermatology, immunology, and allergy. With its ISSN 2233-8276 and E-ISSN 2233-8268, the journal provides a platform for innovative studies and reviews that cater to an international audience of researchers, healthcare professionals, and students involved in allergy and related disorders. Although it does not currently offer open access to its publications, the journal's robust output from 2015 to 2017 and its ongoing contribution to the literature from 2021 to 2024 showcase the evolving landscape of allergy research in the Asia Pacific region. Recognized in the 2023 Journal Citation Reports, it holds a Q2 ranking in Dermatology and a Q3 ranking in Immunology and Allergy, while its Scopus ranks further emphasize its significance within these domains, positioning it among the top journals in the field. As a source of cutting-edge research, Asia Pacific Allergy plays a vital role in fostering collaboration and knowledge dissemination, ultimately assisting in the betterment of patient care and treatment strategies across the region.

CLINICAL OTOLARYNGOLOGY is a prestigious peer-reviewed journal published by Wiley that focuses on advancing research in the field of otorhinolaryngology, including topics such as laryngeal surgery, sinus diseases, and head and neck oncology. With an ISSN of 1749-4478 and an E-ISSN of 1749-4486, this journal has established itself as a vital resource for healthcare professionals, researchers, and students interested in ear, nose, and throat (ENT) medicine. The journal is recognized for its rigorous standards, exemplified by its Q2 ranking in both the Medicine (Miscellaneous) and Otorhinolaryngology categories, as per the 2023 Scopus ranking, placing it within the 71st percentile among global journals in its field. Operating from its UK base in Hoboken, NJ, CLINICAL OTOLARYNGOLOGY also contributes to the scientific community's understanding of this specialized area of medicine, with a publication timeline spanning from 2005 to 2024. While it does not offer an open-access model, the journal's quality and impact make it a crucial platform for disseminating high-caliber research that informs clinical practices and fosters innovation in otolaryngology.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is an esteemed publication dedicated to the fields of Immunology and Allergy, published by ESMON PUBLICIDAD S A in collaboration with the Department of Allergy and Clinical Immunology at the University Clinical Navarra, Spain. With its rich history spanning over three decades since its inception in 1991, this journal has gained prominence in the scientific community, holding a commendable Q2 quartile in Allergy and a Q3 quartile in Immunology. Ranked within the top tiers of its categories according to Scopus, it stands at Rank #80/233 in Immunology and Allergy, and Rank #96/236 in Immunology and Microbiology, indicating its influential role in disseminating cutting-edge research and clinical insights. Though primarily print-focused, the journal strives to bridge gaps in knowledge and contribute to the ongoing dialogue among researchers, professionals, and students in the immunological sciences. The JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is essential for anyone committed to advancing the understanding of allergic and immunological conditions.

Allergy & Rhinology, published by SAGE Publications Inc, is a premier open access journal that has been disseminating critical research since 2011. With a dedicated ISSN of 2152-6567 and an E-ISSN of 2152-6567, this journal serves as an essential platform for scholars in the fields of immunology, allergy, and otorhinolaryngology. Recognized in the 2023 Scopus rankings, it holds a Q3 category in Immunology and Allergy and a Q2 category in Otorhinolaryngology, reflecting its commitment to high-quality research. The journal not only supports the sharing of innovative research ideas and practices but also ensures broader access to new developments within these vital fields, appealing to researchers, clinicians, and students alike. With its headquarters in the United Kingdom and an address in Thousand Oaks, California, Allergy & Rhinology continues to contribute significantly to the advancement of knowledge, helping professionals tackle pressing issues related to allergies and respiratory conditions.

Allergy Asthma & Immunology Research, published by the Korean Academy of Asthma Allergy & Clinical Immunology, is a leading journal dedicated to advancing the fields of immunology, allergy, and respiratory medicine. With an ISSN of 2092-7355 and an E-ISSN of 2092-7363, this esteemed publication has been a cornerstone for researchers and practitioners since its inception in 2009 and continues to disseminate critical findings through till 2024. The journal is ranked in the Q3 category in Immunology and the Q2 category in Immunology and Allergy as well as Pulmonary and Respiratory Medicine, illustrating its impact in these vital fields. With a solid Scopus ranking in multiple sub-disciplines, the journal not only contributes to the scientific discourse but also promotes innovative research and clinical practices. Although currently operating without an open access model, the journal remains highly regarded for its thorough peer-review process and commitment to academic excellence, making it an essential resource for professionals, researchers, and students passionate about advancing knowledge in allergy, asthma, and immunology.

The International Forum of Allergy & Rhinology, published by Wiley, is a leading journal dedicated to advancing the field of allergy, rhinology, and related health issues. With an ISSN of 2042-6976 and an E-ISSN of 2042-6984, this esteemed journal showcases high-quality research and innovative findings by publishing original articles, reviews, and clinical case studies. As of 2023, it holds impressive rankings within the Scopus metrics, placing it in the top 2% for Medicine in Otorhinolaryngology and in the top 16% for Immunology and Allergy, highlighting its influence and credibility in these specialized fields. Operating without an open access model, the journal aims to offer comprehensive insights into the diagnosis and treatment of allergic conditions and their impact on rhinology, fostering a deeper understanding among researchers and practitioners. Located in Hoboken, NJ, the journal has been at the forefront of scientific exploration since its inception in 2011, continuing to play a pivotal role in informing the academic community and influencing clinical practice up to 2024 and beyond.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, published by KARGER, is a distinguished journal dedicated to advancing the field of immunology and allergy research. With an ISSN of 1018-2438 and an E-ISSN of 1423-0097, this journal has been a vital resource since its inception in 1950, continuing to publish influential articles through 2024. Hailing from Switzerland, it holds an important position within the Q3 category in Immunology and Allergy and Q2 in miscellaneous Medicine, reflecting its growing impact in the scientific community. The Scopus rankings showcase its relevance, with a 52nd percentile in Immunology and Allergy and 45th in Immunology and Microbiology. Although not an open-access journal, it plays a critical role in disseminating significant findings and innovations in the understanding of allergic diseases and immunological responses. The INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY is essential for researchers, clinicians, and students eager to stay at the forefront of allergy and immunology developments.

The Journal of Allergy and Clinical Immunology-In Practice, published by ELSEVIER, stands as a leading platform in the field of allergy and immunology, specifically tailored for practitioners and researchers. With an impressive 2023 Q1 ranking in both the Immunology and Allergy categories, this journal demonstrates a significant impact within the academic community, evidenced by its Scopus rank #41 out of 233 and an impressive percentile rank of 82. The journal focuses on providing advanced studies, clinical findings, and innovative treatment methodologies that address current challenges in allergy and immunology, making it a vital resource for professionals in these fields. With a comprehensive coverage of relevant topics from 2013 to 2024, the journal continues to evolve alongside emerging trends and developments in clinical practice, fostering an environment conducive to scholarly research and application. Although it currently does not offer open access, authors and readers can access a wealth of information and contribute to ongoing dialogues through its robust publication platform.